ABVC BioPharma Inc (ABVC)
1.08
-0.07
(-6.09%)
USD |
NASDAQ |
May 03, 16:00
1.13
+0.05
(+4.63%)
After-Hours: 20:00
ABVC BioPharma Debt to Equity Ratio: 0.1751 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.1751 |
September 30, 2023 | 0.2754 |
June 30, 2023 | -11.03 |
March 31, 2023 | 2.460 |
December 31, 2022 | 0.6112 |
September 30, 2022 | 0.3153 |
June 30, 2022 | 0.1686 |
March 31, 2022 | 0.2412 |
December 31, 2021 | 0.1854 |
September 30, 2021 | 0.2243 |
June 30, 2021 | 3.178 |
March 31, 2021 | 1.772 |
December 31, 2020 | 1.370 |
September 30, 2020 | -4.754 |
June 30, 2020 | -3.786 |
March 31, 2020 | -3.625 |
December 31, 2019 | -26.76 |
September 30, 2019 | 5.650 |
June 30, 2019 | -0.9419 |
March 31, 2019 | -0.5615 |
December 31, 2018 | -0.1391 |
September 30, 2018 | -0.2246 |
June 30, 2018 | -0.2458 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 1.342 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.2337 |
March 31, 2015 | 0.244 |
December 31, 2014 | 0.237 |
September 30, 2014 | 0.2232 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.6787 |
June 30, 2012 | -0.7036 |
March 31, 2012 | -0.6202 |
December 31, 2011 | -0.8107 |
September 30, 2011 | -0.7859 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-26.76
Minimum
Dec 2019
5.650
Maximum
Sep 2019
-1.803
Average
0.2243
Median
Sep 2021
Debt to Equity Ratio Benchmarks
NeuBase Therapeutics Inc | -- |
Sutro Biopharma Inc | 0.0271 |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | 0.3015 |
Journey Medical Corp | 0.7185 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 14.49M |
Total Liabilities (Quarterly) | 6.362M |
Shareholders Equity (Quarterly) | 8.388M |
Current Ratio | 0.2793 |
Net Debt Paydown Yield | 0.87% |